654 related articles for article (PubMed ID: 6646897)
21. Long-chain fatty acid oxidation during early human development.
Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
[TBL] [Abstract][Full Text] [Related]
22. Influence of valproic acid on the expression of various acyl-CoA dehydrogenases in rats.
Kibayashi M; Nagao M; Chiba S
Pediatr Int; 1999 Feb; 41(1):52-60. PubMed ID: 10200137
[TBL] [Abstract][Full Text] [Related]
23. Medium-chain acyl-CoA dehydrogenase deficiency.
Egidio RJ; Francis GL; Coates PM; Hale DE; Roesel A
Am Fam Physician; 1989 May; 39(5):221-6. PubMed ID: 2718899
[TBL] [Abstract][Full Text] [Related]
24. Carnitine and carnitine palmitoyltransferase in fatty acid oxidation and ketosis.
Hoppel CL
Fed Proc; 1982 Oct; 41(12):2853-7. PubMed ID: 7128831
[TBL] [Abstract][Full Text] [Related]
25. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
[TBL] [Abstract][Full Text] [Related]
26. [Medium-chain acyl-CoA dehydrogenase defect. Acute cerebral episodes and nonketotic hypoglycemia in children].
von Mühlendahl KE; Lehnert W; Mönch E
Dtsch Med Wochenschr; 1990 Aug; 115(33):1235-8. PubMed ID: 2387217
[TBL] [Abstract][Full Text] [Related]
27. A case of impairment of mitochondrial fatty acid beta-oxidation.
Hasegawa T; Hori N; Du W
Keio J Med; 2002 Jun; 51(2):100-6. PubMed ID: 12125906
[TBL] [Abstract][Full Text] [Related]
28. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
[TBL] [Abstract][Full Text] [Related]
29. Influence of dietary fatty acid chain-length on metabolic tolerance in mouse models of inherited defects in mitochondrial fatty acid beta-oxidation.
Schuler AM; Gower BA; Matern D; Rinaldo P; Wood PA
Mol Genet Metab; 2004 Dec; 83(4):322-9. PubMed ID: 15589119
[TBL] [Abstract][Full Text] [Related]
30. Sudden child death and 'healthy' affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency.
Duran M; Hofkamp M; Rhead WJ; Saudubray JM; Wadman SK
Pediatrics; 1986 Dec; 78(6):1052-7. PubMed ID: 3786030
[TBL] [Abstract][Full Text] [Related]
31. [Generalized epilepsy disclosing medium-chain-acyl-CoA dehydrogenase deficiency].
Chabrol B; Mancini J; Bertrand C; Vianey-Saban C; Divry P; Livet MO; Pinsard N
Arch Fr Pediatr; 1993; 50(6):497-500. PubMed ID: 8135611
[TBL] [Abstract][Full Text] [Related]
32. Fasting-induced oxidative stress in very long chain acyl-CoA dehydrogenase-deficient mice.
Tucci S; Primassin S; Spiekerkoetter U
FEBS J; 2010 Nov; 277(22):4699-708. PubMed ID: 20883455
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse.
Brix AE; Elgavish A; Nagy TR; Gower BA; Rhead WJ; Wood PA
Mol Genet Metab; 2002 Mar; 75(3):219-26. PubMed ID: 11914033
[TBL] [Abstract][Full Text] [Related]
34. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.
Westermann CM; Dorland L; Votion DM; de Sain-van der Velden MG; Wijnberg ID; Wanders RJ; Spliet WG; Testerink N; Berger R; Ruiter JP; van der Kolk JH
Neuromuscul Disord; 2008 May; 18(5):355-64. PubMed ID: 18406615
[TBL] [Abstract][Full Text] [Related]
35. Alterations of fatty acid β-oxidation capability in the liver of ketotic cows.
Li P; Li XB; Fu SX; Wu CC; Wang XX; Yu GJ; Long M; Wang Z; Liu GW
J Dairy Sci; 2012 Apr; 95(4):1759-66. PubMed ID: 22459824
[TBL] [Abstract][Full Text] [Related]
36. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
Treem WR; Rinaldo P; Hale DE; Stanley CA; Millington DS; Hyams JS; Jackson S; Turnbull DM
Hepatology; 1994 Feb; 19(2):339-45. PubMed ID: 8294091
[TBL] [Abstract][Full Text] [Related]
37. Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts.
Pande SV; Brivet M; Slama A; Demaugre F; Aufrant C; Saudubray JM
J Clin Invest; 1993 Mar; 91(3):1247-52. PubMed ID: 8450053
[TBL] [Abstract][Full Text] [Related]
38. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
[TBL] [Abstract][Full Text] [Related]
39. Complementation analysis of fatty acid oxidation disorders.
Moon A; Rhead WJ
J Clin Invest; 1987 Jan; 79(1):59-64. PubMed ID: 3793932
[TBL] [Abstract][Full Text] [Related]
40. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.
Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Ijlst L; Vaz FM; van Vlies N; Overmars H; Duran M; Wijburg FA; Wanders RJ; Strauss AW
Pediatr Res; 2005 Jun; 57(6):760-4. PubMed ID: 15774826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
